Couverture de NP Certification Q&A

NP Certification Q&A

NP Certification Q&A

De : Fitzgerald Health Education Associates
Écouter gratuitement

3 mois pour 0,99 €/mois

Après 3 mois, 9.95 €/mois. Offre soumise à conditions.

À propos de ce contenu audio

Welcome to NP Certification Q&A presented by Fitzgerald Health Education Associates. This podcast is for NP students studying to pass their NP certification exam. Getting to the correct test answers means breaking down the exam questions themselves. Expert Fitzgerald faculty clinicians share their knowledge and experience to help you dissect the anatomy of a test question so you can better understand how to arrive at the correct test answer. So, if you’re ready, let’s jump right in.

© 2026 NP Certification Q&A
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Épisodes
    • Hepatitis B
      Jan 19 2026

      A 35-year-old man presents with a one-week history of new onset fatigue, nausea, as well as reporting his urine looks like, quote, ice tea. He also reports, feel like someone kicked me right underneath my ribs on the right. He denies recent travel, contact with individuals with similar signs and symptoms, and reports a new sex partner for the past six months, stating, quote, we sometimes use condoms.

      In considering the diagnosis of acute hepatitis B, which of the following laboratory profiles would be noted?

      A. Hep B surface antigen positive, anti-HBs negative, or Hep B surface antibody. ALT markedly elevated at 1390. AST similarly elevated at 1100. Total bilirubin markedly elevated at 4.8

      B. Hep B surface antigen positive, anti-HBs, HBS- or Hep B surface antibody ALT modestly elevated at 68 as is AST total bilirubin .9 within normal limits

      C. Hep B surface antigen negative, anti-HBS- or Hep B surface antibody, ALT 24, AST 22 and a total bilirubin of 0.6

      D. Hep B surface antigen negative, anti-HPS negative, ALT 150, AST 140, total bilirubin 0.7 within normal limits


      Visit fhea.com to learn more!

      Afficher plus Afficher moins
      21 min
    • Sliding Scale Insulin
      Jan 12 2026

      A 73-year-old female with a 20-year history of hypertension, type 2 diabetes, dyslipidemia, and stage 3B CKD, typically at treatment goals with oral medications, is being seen. She was discharged yesterday after being hospitalized for three days with community-acquired pneumonia and is here for a follow-up visit.

      She states she's feeling much better with less shortness of breath, diminished cough, and sputum production, and is without fever. She mentions that while she was in the hospital that, quote, they changed my diabetes medicine and gave me insulin four times a day to keep my sugar controlled, close quote. A review of her discharge note reveals that rapid acting insulin was given according to blood glucose levels without scheduled basal insulin and this was used from admission to discharge.

      Random glucose today is at 220. The patient asks, should I start back up on those insulin shots? I've never used them before. The NP considers with which of the following.

      A. given her random blood glucose is elevated, the use of a sliding scale insulin should be continued for the next week

      B. the use of a sliding scale insulin potentially results in wide glucose excursions

      C. sliding scale insulin is helpful as it mimics physiologic insulin secretion

      D. the sliding scale insulin regimen should now be replaced with a basal insulin

      ---

      YouTube: https://www.youtube.com/watch?v=Pig89cLdQ5k&list=PLf0PFEPBXfq592b5zCthlxSNIEM-H-EtD&index=125

      Visit fhea.com to learn more!

      Afficher plus Afficher moins
      17 min
    • Treating Type 2 Diabetes with ASCVD
      Jan 6 2026

      A 60-year-old male with documented ASCVD, obesity with BMI of 34, and type 2 diabetes presents for care. The patient reports he's currently feeling well without episodes of hypoglycemia. Current laboratory assessment includes the following. A1C is 8.6 % and his estimated GFR is at 62. Current medications include metformin at optimized dose and a sulfonyl urea.

      Which of the following represents the nurse practitioner's next best action?

      A. continue on current therapy and arrange for a three month follow up

      B. discontinue the metformin and add a DPP4 inhibitor

      C. add a GLP-1 inhibitor and discontinue the sulfonyl urea

      D. add basal insulin and titrate to fasting glycemic goals

      ---

      YouTube: https://www.youtube.com/watch?v=8ybH1qcskq8&list=PLf0PFEPBXfq592b5zCthlxSNIEM-H-EtD&index=124

      Visit fhea.com to learn more!

      Afficher plus Afficher moins
      16 min
    Aucun commentaire pour le moment